Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
531-542
Author(s):
R. Lappano, C. Rosano, M. F. Santolla, M. Pupo, E. M. De Francesco, P. De Marco, M. Ponassi, A. Spallarossa, A. Ranise and M. Maggiolini
Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
6
Page:
136-138
Author(s):
Parvaneh Ehsanzadeh-Cheemeh, Michelle Thompson and Michal Miller
Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
6
Page:
171-176
Author(s):
Giuseppe Pasqualetti, Sergio Ricci, Giuseppe Boni, Sara Tognini, Antonio Polini, Giuliano Mariani, Marco Ferdeghini and Fabio Monzani
Patent Selections:
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
6
Page:
177-179
Author(s):
Bentham Science Publishers
Peptide-Receptor Ligands and Multivalent Approach
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
12
Page:
416-427
Author(s):
Paolo Ruzza, Anna Marchiani, Nicola Antolini and Andrea Calderan
Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
12
Page:
526-542
Author(s):
Giampiero Giovacchini, Guillaume Nicolas and Flavio Forrer
Boronated Compounds for Imaging Guided BNCT Applications
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
12
Page:
543-553
Author(s):
Simonetta Geninatti-Crich, Annamaria Deagostino, Antonio Toppino, Diego Alberti, Paolo Venturello and Silvio Aime
Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
12
Page:
663-671
Author(s):
Ulrike Olszewski, Robert Zeillinger, Meltem Demirel Kars, Attila Zalatnai, Jozsef Molnar and Gerhard Hamilton
Anti-VEGF Strategies – from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2680-2701
Author(s):
Grzegorz Korpanty and Elizabeth Smyth
Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2702-2712
Author(s):
Marco Petrillo, Maddalena Borriello, Gilda Fuoco, Francesco Legge, Vito Iannone and Gabriella Ferrandina